Dr Reddy's Laboratories settles Clarinex ANDA patent litigation with Schering and Sepracor

Published: 5-Jan-2009

Dr Reddy's Laboratories has entered into agreements with Schering and Sepracor that will allow it to manufacture and market generic versions of the Clarinex-D-12 Hour and Clarinex-D-24 Hour products, with six months marketing exclusivity, and the Clarinex Reditabs product, with six months marketing co-exclusivity, starting in 2012.


Dr Reddy's Laboratories has entered into agreements with Schering and Sepracor that will allow it to manufacture and market generic versions of the Clarinex-D-12 Hour and Clarinex-D-24 Hour products, with six months marketing exclusivity, and the Clarinex Reditabs product, with six months marketing co-exclusivity, starting in 2012.

Dr Reddy's will also market a generic version of the Clarinex 5mg tablet six months after the launch of the first generic version of that product.

The agreements resolve all pending patent infringement actions filed by Schering and Sepracor against Dr Reddy's in the US District Court for the District of New Jersey. The specific financial terms and conditions have not been disclosed.

See more

You may also like

Dosage Forms

Extrovis and Dr. Reddy’s launch an authorised generic CARAC (fluorouracil cream) 0.5% in the US

Read more
The partnership reinforces Extrovis’ strategy to extend the reach of its therapeutics while advancing long-term affordability and sustainability in healthcare

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Dosage Forms

Extrovis and Dr. Reddy’s launch an authorised generic CARAC (fluorouracil cream) 0.5% in the US

The partnership reinforces Extrovis’ strategy to extend the reach of its therapeutics while advancing long-term affordability and sustainability in healthcare
Research & Development

Aurigene Pharmaceutical Services Limited and Edity announce a strategic collaboration in cell therapy

Aurigene will provide cell therapy discovery services to Edity to support the latter’s clinical development
Manufacturing

Aurigene expands CDMO facilities for viral vectors

The facility allows for maximum flexibility for a multi-product, multi-platform offering across therapeutic proteins, antibodies, and viral vectors
Manufacturing

Dr. Reddy’s Hyderabad factory joins Global Lighthouse Network

The  journey started four years ago with digitisation of infrastructure and processes. Two years ago, Project ‘OpsNext’ saw deployment of six Industry 4.0 technologies
Research & Development

Manufacturing Chemist Live: Day One Review

The first day of MC Live has now concluded, with attendees enjoying presentations from STA Pharmaceuticals, NSF International and Lonza, among others
Manufacturing

Big names announced for leading Pharma and Cleanroom conference

The Cleanroom Technology Conference and Manufacturing Chemist Live collaboration will take place on the 10-11 November. Delegate tickets are currently available
Regulatory

Several large Indian pharma companies under US FDA scrutiny

Recent regulatory action by the FDA on leading Indian firms has affected the country's exports, according to Chairman of Dr. Reddy's Laboratories
Subscribe now